CONCOR AMLO

This brand name is authorized in Germany, Hong Kong SAR China, Tunisia.

Active ingredients

The drug CONCOR AMLO contains a combination of these active pharmaceutical ingredients (APIs):

1	Bisoprolol UNII UR59KN573L - BISOPROLOL FUMARATE
	Bisoprolol is a potent highly beta1-selective-adrenoceptor blocking agent, lacking intrinsic stimulating and without relevant membrane stabilising activity.
	Read more about Bisoprolol
2	Amlodipine UNII 864V2Q084H - AMLODIPINE BESYLATE
	Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.
	Read more about Amlodipine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C07FB07		C Cardiovascular system → C07 Beta blocking agents → C07F Beta blocking agents and other antihypertensives → C07FB Beta blocking agents, selective, and other antihypertensives
Discover more medicines within C07FB07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	16685715, 16685721, 16685738, 16685744
HK	Department of Health Drug Office	66319, 66320, 66321, 66322
TN	Direction de la Pharmacie et du Médicament	15423011, 15423012, 15423013, 15423014